Synthesis and evaluation of a spiro-isobenzofuranone class of histamine H3 receptor inverse agonists

被引:17
|
作者
Jitsuoka, Makoto [1 ]
Tsukahara, Daisuke [1 ]
Ito, Sayaka [1 ]
Tanaka, Takeshi [1 ]
Takenaga, Norihiro [1 ]
Tokita, Shigeru [1 ]
Sato, Nagaaki [1 ]
机构
[1] Banyu Pharmaceut Co Ltd, Merck Res Labs, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan
关键词
histamine H-3 inverse agonist; spiro-isobenzofuranone; PET tracer; brain permeability;
D O I
10.1016/j.bmcl.2008.07.125
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Spiro-isobenzofuranones 1a and 1b were discovered as potent, selective, and brain-penetrable non-imidazole H-3 receptor inverse agonists. Our corporate sample collection was screened to identify 2a as a lead. Recognizing the right-hand portion of 2a as an essential pharmacophore, an extensive screen of the left-hand piperidine portion was carried out to yield the potent spiro-derivatives 2t-x. Spiro-isobenzofuranone 2x, the most potent among the derivatives, was converted to the corresponding amide 1a, which possessed dramatically improved H3 activity (IC50 = 0.72 nM; more than 20-fold improvement over 2x). Further elaboration led to the identification of 1b, a 5-methoxy derivative with an IC50 of 0.54 nM. Our studies demonstrated that derivatives 1a and 1b to be potent, selective, and brain-penetrable H-3 inverse agonists. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5101 / 5106
页数:6
相关论文
共 50 条
  • [41] Histamine H3 receptor antagonists/inverse agonists: a patent review (October 2017-December 2023) documenting progress
    Lazewska, Dorota
    Kiec-Kononowicz, Katarzyna
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 35 (03) : 251 - 275
  • [42] New therapeutic alternatives in migraine prophylaxis using histamine H3 receptor agonists
    Millan-Guerrero, Rebeca O.
    Isais-Millan, Rebeca
    GACETA MEDICA DE MEXICO, 2008, 144 (04): : 291 - 295
  • [43] Novel partial agonists for the histamine H3 receptor with high in vitro and in vivo activity
    Sasse, A
    Stark, H
    Reidemeister, S
    Hüls, A
    Elz, S
    Ligneau, X
    Ganellin, CR
    Schwartz, JC
    Schunack, W
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) : 4269 - 4274
  • [44] The histamine H3 receptor:: From gene cloning to H3 receptor drugs
    Leurs, R
    Bakker, RA
    Timmerman, H
    de Esch, IJP
    NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (02) : 107 - U18
  • [45] Design, synthesis, and anticonvulsant effects evaluation of nonimidazole histamine H3receptor antagonists/inverse agonists containing triazole moiety
    Song, Mingxia
    Yan, Rui
    Zhang, Yanhui
    Guo, Dongfu
    Zhou, Naiming
    Deng, XianQing
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1310 - 1321
  • [46] Design and Evaluation of Novel Biphenyl Sulfonamide Derivatives with Potent Histamine H3 Receptor Inverse Agonist Activity
    Covel, Jonathan A.
    Santora, Vincent J.
    Smith, Jeffrey M.
    Hayashi, Rena
    Gallardo, Charlemagne
    Weinhouse, Michael I.
    Ibarra, Jason B.
    Schultz, Jeffrey A.
    Park, Douglas M.
    Estrada, Scott A.
    Hofilena, Brian J.
    Pulley, Michelle D.
    Smith, Brian M.
    Ren, Albert
    Suarez, Marissa
    Frazer, John
    Edwards, Jeffrey
    Hauser, Erin K.
    Lorca, Jodie
    Semple, Graeme
    Grottick, Andrew J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (18) : 5603 - 5611
  • [47] Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil
    Uguen, M.
    Perrin, D.
    Belliard, S.
    Ligneau, X.
    Beardsley, P. M.
    Lecomte, J. M.
    Schwartz, J. C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (03) : 632 - 644
  • [48] Radiosynthesis of a Histamine H3 receptor antagonist:: In vitro and in vivo evaluation
    Airaksinen, Ann J.
    Jablonowski, J. A.
    van der Mey, M.
    Barbier, A. J.
    Klok, R. P.
    Verbeek, J.
    Schuit, R. C.
    Herscheid, J. D. M.
    Lammertsma, A. A.
    Carruthers, B. I.
    Leysen, J. E.
    Windhorst, A. D.
    NEUROIMAGE, 2006, 31 : T46 - T46
  • [49] 4-benzyl-1H-imidazoles with oxazoline termini as histamine H3 receptor agonists
    Wijtmans, Maikel
    Celanire, Sylvain
    Snip, Erwin
    Gillard, Michel R.
    Gelens, Edith
    Collart, Philippe P.
    Venhuis, Bastiaan J.
    Christophe, Bernard
    Hulscher, Saskia
    van der Goot, Henk
    Lebon, Florence
    Timmerman, Henk
    Bakker, Remko A.
    Lallemand, Benedicte I. L. F.
    Leurs, Rob
    Talaga, Patrice E.
    de Esch, Iwan J. P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (10) : 2944 - 2953
  • [50] Ergoline-Derived Inverse Agonists of the Human H3 Receptor for the Treatment of Narcolepsy
    Auberson, Yves P.
    Troxler, Thomas
    Zhang, Xuechun
    Yang, Charles R.
    Fendt, Markus
    Feuerbach, Dominik
    Liu, Yu-Chih
    Lagu, Bharat
    Lerchner, Andreas
    Perrone, Mark
    Lei, Lijun
    Zhang, Chao
    Wang, Chunxiu
    Wang, Tie-Lin
    Bock, Mark G.
    CHEMMEDCHEM, 2014, 9 (08) : 1683 - 1696